Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Periostin Promotes Cell Proliferation and Macrophage Polarization to Drive Repair after AKI.

Kormann R, Kavvadas P, Placier S, Vandermeersch S, Dorison A, Dussaule JC, Chadjichristos CE, Prakoura N, Chatziantoniou C.

J Am Soc Nephrol. 2019 Nov 5. pii: ASN.2019020113. doi: 10.1681/ASN.2019020113. [Epub ahead of print]

PMID:
31690575
2.

Urothelium proliferation is a trigger for renal crystal deposits in a murine lithogenesis model.

Bilbault H, Perez J, Huguet L, Vandermeersch S, Placier S, Tabibzadeh N, Frochot V, Letavernier E, Bazin D, Daudon M, Haymann JP.

Sci Rep. 2018 Nov 5;8(1):16319. doi: 10.1038/s41598-018-34734-8.

3.

Notch3 orchestrates epithelial and inflammatory responses to promote acute kidney injury.

Kavvadas P, Keuylian Z, Prakoura N, Placier S, Dorison A, Chadjichristos CE, Dussaule JC, Chatziantoniou C.

Kidney Int. 2018 Jul;94(1):126-138. doi: 10.1016/j.kint.2018.01.031. Epub 2018 May 8.

PMID:
29751972
4.

Genetically increased angiotensin I-converting enzyme alters peripheral and renal vascular reactivity to angiotensin II and bradykinin in mice.

Chollet C, Placier S, Chatziantoniou C, Hus-Citharel A, Caron N, Roussel R, Alhenc-Gelas F, Bouby N.

Am J Physiol Heart Circ Physiol. 2018 Feb 1;314(2):H350-H358. doi: 10.1152/ajpheart.00356.2017. Epub 2017 Nov 3.

5.

Endothelial Epas1 Deficiency Is Sufficient To Promote Parietal Epithelial Cell Activation and FSGS in Experimental Hypertension.

Luque Y, Lenoir O, Bonnin P, Hardy L, Chipont A, Placier S, Vandermeersch S, Xu-Dubois YC, Robin B, Lazareth H, Souyri M, Guyonnet L, Baudrie V, Camerer E, Rondeau E, Mesnard L, Tharaux PL.

J Am Soc Nephrol. 2017 Dec;28(12):3563-3578. doi: 10.1681/ASN.2016090960. Epub 2017 Sep 19.

6.

Specific calpain inhibition protects kidney against inflammaging.

Hanouna G, Mesnard L, Vandermeersch S, Perez J, Placier S, Haymann JP, Campagne F, Moroch J, Bataille A, Baud L, Letavernier E.

Sci Rep. 2017 Aug 14;7(1):8016. doi: 10.1038/s41598-017-07922-1.

7.

Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritis.

Luque Y, Cathelin D, Vandermeersch S, Xu X, Sohier J, Placier S, Xu-Dubois YC, Louis K, Hertig A, Bories JC, Vasseur F, Campagne F, Di Santo JP, Vosshenrich C, Rondeau E, Mesnard L.

Kidney Int. 2017 May;91(5):1146-1158. doi: 10.1016/j.kint.2016.10.037. Epub 2017 Jan 19.

8.

Vancomycin-Associated Cast Nephropathy.

Luque Y, Louis K, Jouanneau C, Placier S, Esteve E, Bazin D, Rondeau E, Letavernier E, Wolfromm A, Gosset C, Boueilh A, Burbach M, Frère P, Verpont MC, Vandermeersch S, Langui D, Daudon M, Frochot V, Mesnard L.

J Am Soc Nephrol. 2017 Jun;28(6):1723-1728. doi: 10.1681/ASN.2016080867. Epub 2017 Jan 12.

9.

Plasma heme-induced renal toxicity is related to a capillary rarefaction.

Tabibzadeh N, Estournet C, Placier S, Perez J, Bilbault H, Girshovich A, Vandermeersch S, Jouanneau C, Letavernier E, Hammoudi N, Lionnet F, Haymann JP.

Sci Rep. 2017 Jan 10;7:40156. doi: 10.1038/srep40156.

10.

Stress Response Gene Nupr1 Alleviates Cyclosporin A Nephrotoxicity In Vivo.

Galichon P, Bataille A, Vandermeersch S, Wetzstein M, Xu-Dubois YC, Legouis D, Hertig A, Buob D, Placier S, Bigé N, Lefevre G, Jouanneau C, Martin C, Iovanna JL, Rondeau E.

J Am Soc Nephrol. 2017 Feb;28(2):545-556. doi: 10.1681/ASN.2015080936. Epub 2016 Jul 22.

11.

Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration.

Amador CA, Bertocchio JP, Andre-Gregoire G, Placier S, Duong Van Huyen JP, El Moghrabi S, Berger S, Warnock DG, Chatziantoniou C, Jaffe IZ, Rieu P, Jaisser F.

Kidney Int. 2016 Feb;89(2):354-62.

12.

Distinct protein signature of hypertension-induced damage in the renal proteome of the two-kidney, one-clip rat model.

Vethe H, Finne K, Skogstrand T, Vaudel M, Vikse BE, Hultström M, Placier S, Scherer A, Tenstad O, Marti HP.

J Hypertens. 2015 Jan;33(1):126-35. doi: 10.1097/HJH.0000000000000370.

PMID:
25304470
13.

Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice.

Cathelin D, Placier S, Ploug M, Verpont MC, Vandermeersch S, Luque Y, Hertig A, Rondeau E, Mesnard L.

J Am Soc Nephrol. 2014 Aug;25(8):1662-8. doi: 10.1681/ASN.2013040425. Epub 2014 May 1.

14.

Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis.

Kerroch M, Guerrot D, Vandermeersch S, Placier S, Mesnard L, Jouanneau C, Rondeau E, Ronco P, Boffa JJ, Chatziantoniou C, Dussaule JC.

FASEB J. 2012 Oct;26(10):4079-91. doi: 10.1096/fj.11-194902. Epub 2012 Jul 2.

PMID:
22751008
15.

Ureteral obstruction promotes proliferation and differentiation of the renal urothelium into a bladder-like phenotype.

Girshovich A, Vinsonneau C, Perez J, Vandermeersch S, Verpont MC, Placier S, Jouanneau C, Letavernier E, Baud L, Haymann JP.

Kidney Int. 2012 Aug;82(4):428-35.

16.

Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy.

Guerrot D, Dussaule JC, Mael-Ainin M, Xu-Dubois YC, Rondeau E, Chatziantoniou C, Placier S.

PLoS One. 2012;7(3):e31974. doi: 10.1371/journal.pone.0031974. Epub 2012 Mar 5.

17.

Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release.

Zafrani L, Gerotziafas G, Byrnes C, Hu X, Perez J, Lévi C, Placier S, Letavernier E, Leelahavanichkul A, Haymann JP, Elalamy I, Miller JL, Star RA, Yuen PS, Baud L.

Am J Respir Crit Care Med. 2012 Apr 1;185(7):744-55. doi: 10.1164/rccm.201109-1686OC. Epub 2012 Jan 20.

18.

Detection of intrarenal microstructural changes with supersonic shear wave elastography in rats.

Derieppe M, Delmas Y, Gennisson JL, Deminière C, Placier S, Tanter M, Combe C, Grenier N.

Eur Radiol. 2012 Jan;22(1):243-50. doi: 10.1007/s00330-011-2229-9. Epub 2011 Aug 16.

PMID:
21845464
19.

Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy.

Guerrot D, Kerroch M, Placier S, Vandermeersch S, Trivin C, Mael-Ainin M, Chatziantoniou C, Dussaule JC.

Am J Pathol. 2011 Jul;179(1):83-91. doi: 10.1016/j.ajpath.2011.03.023. Epub 2011 May 13.

20.

Notch3 is essential for regulation of the renal vascular tone.

Boulos N, Helle F, Dussaule JC, Placier S, Milliez P, Djudjaj S, Guerrot D, Joutel A, Ronco P, Boffa JJ, Chatziantoniou C.

Hypertension. 2011 Jun;57(6):1176-82. doi: 10.1161/HYPERTENSIONAHA.111.170746. Epub 2011 Apr 25.

PMID:
21518968
21.

Intrarenal urothelium proliferation: an unexpected early event following ischemic injury.

Vinsonneau C, Girshovich A, M'rad MB, Perez J, Mesnard L, Vandermersch S, Placier S, Letavernier E, Baud L, Haymann JP.

Am J Physiol Renal Physiol. 2010 Sep;299(3):F479-86. doi: 10.1152/ajprenal.00585.2009. Epub 2010 Jun 30.

22.

Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.

Helle F, Jouzel C, Chadjichristos C, Placier S, Flamant M, Guerrot D, François H, Dussaule JC, Chatziantoniou C.

Am J Physiol Renal Physiol. 2009 Jul;297(1):F191-9. doi: 10.1152/ajprenal.00015.2009. Epub 2009 May 6.

23.

Role of matrix metalloproteinases in early hypertensive vascular remodeling.

Flamant M, Placier S, Dubroca C, Esposito B, Lopes I, Chatziantoniou C, Tedgui A, Dussaule JC, Lehoux S.

Hypertension. 2007 Jul;50(1):212-8. Epub 2007 May 21.

PMID:
17515450
24.

Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease.

Flamant M, Placier S, Rodenas A, Curat CA, Vogel WF, Chatziantoniou C, Dussaule JC.

J Am Soc Nephrol. 2006 Dec;17(12):3374-81. Epub 2006 Nov 8.

25.

[Renal hemodynamics and development of renal fibrotic lesions during hypertension].

Placier S, Flamant M, Boffa JJ, Dussaule JC, Chatziantoniou C.

Arch Mal Coeur Vaiss. 2006 Jul-Aug;99(7-8):697-700. French.

PMID:
17061447
26.

Reversal of renal lesions following interruption of nitric oxide synthesis inhibition in transgenic mice.

Placier S, Boffa JJ, Dussaule JC, Chatziantoniou C.

Nephrol Dial Transplant. 2006 Apr;21(4):881-8. Epub 2005 Dec 29.

PMID:
16384829
27.

Urinary endothelin-1 as a marker of renal damage in sickle cell disease.

Tharaux PL, Hagège I, Placier S, Vayssairat M, Kanfer A, Girot R, Dussaule JC.

Nephrol Dial Transplant. 2005 Nov;20(11):2408-13. Epub 2005 Sep 6.

PMID:
16144850
28.

Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.

François H, Placier S, Flamant M, Tharaux PL, Chansel D, Dussaule JC, Chatziantoniou C.

FASEB J. 2004 May;18(7):926-8. Epub 2004 Mar 19.

PMID:
15033924
29.

Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases.

Boffa JJ, Lu Y, Placier S, Stefanski A, Dussaule JC, Chatziantoniou C.

J Am Soc Nephrol. 2003 May;14(5):1132-44.

30.

Epidermal growth factor receptor trans-activation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice.

Flamant M, Tharaux PL, Placier S, Henrion D, Coffman T, Chatziantoniou C, Dussaule JC.

FASEB J. 2003 Feb;17(2):327-9. Epub 2002 Dec 3.

PMID:
12475899
31.

Angiotensin II activates collagen type I gene in the renal cortex and aorta of transgenic mice through interaction with endothelin and TGF-beta.

Fakhouri F, Placier S, Ardaillou R, Dussaule JC, Chatziantoniou C.

J Am Soc Nephrol. 2001 Dec;12(12):2701-10.

32.

Regulation of ANP clearance receptors by EGF in mesangial cells from NOD mice.

Placier S, Bretot X, Ardaillou N, Dussaule JC, Ardaillou R.

Am J Physiol Renal Physiol. 2001 Aug;281(2):F244-54.

33.
34.

Mesangial cells from diabetic NOD mice constitutively express increased density of atrial natriuretic peptide C receptors.

Ardaillou N, Placier S, Striker L, Striker G, Ardaillou R.

Kidney Int. 1999 Apr;55(4):1293-302.

35.

Characterization of B2-bradykinin receptors in rabbit principal cells of the collecting duct.

Ardaillou N, Placier S, Zhao J, Baudouin B, Ardaillou R.

Exp Nephrol. 1998 Nov-Dec;6(6):534-41.

PMID:
9807025
36.

Prostaglandin E2 enhances type 2-bradykinin receptor expression in human glomerular podocytes.

Costenbader K, Ardaillou N, Marchetti J, Placier S, Ardaillou R.

Biochim Biophys Acta. 1997 Sep 11;1358(2):142-52.

37.

Receptors for natriuretic peptides in a human cortical collecting duct cell line.

Millul V, Ardaillou N, Placier S, Baudouin B, Ronco PM.

Kidney Int. 1997 Jan;51(1):281-7. Erratum in: Kidney Int 1997 Mar;51(3):979.

38.

Dexamethasone upregulates ANP C-receptor protein in human mesangial cells without affecting mRNA.

Ardaillou N, Blaise V, Placier S, Amestoy F, Ardaillou R.

Am J Physiol. 1996 Mar;270(3 Pt 2):F440-6.

PMID:
8780246
39.

Characterization of C-type natriuretic peptide receptors in human mesangial cells.

Zhao J, Ardaillou N, Lu CY, Placier S, Pham P, Badre L, Cambar J, Ardaillou R.

Kidney Int. 1994 Sep;46(3):717-25.

40.

Interferon-gamma induces dipeptidylpeptidase IV expression in human glomerular epithelial cells.

Stefanovic V, Ardaillou N, Vlahovic P, Placier S, Ronco P, Ardaillou R.

Immunology. 1993 Nov;80(3):465-70.

41.

Release of cyclic nucleotides from the apical and basolateral poles of cultured human glomerular epithelial cells.

Ardaillou N, Placier S, Wahbe F, Ronco P, Ardaillou R.

Exp Nephrol. 1993 Jul-Aug;1(4):253-60.

PMID:
8081975

Supplemental Content

Loading ...
Support Center